Skip to main content
OpenTrials

Clinical trial condition

Pulmonary Disease, Chronic Obstructive

Explore clinical trials studying Pulmonary Disease, Chronic Obstructive. Study availability and eligibility vary by location and protocol.

787 public trials 11 recruiting studies
Refine in advanced search Browse all conditions

Pulmonary Disease, Chronic Obstructive trial results

Completed

INTREPID: Investigation of TRELEGY Effectiveness: Usual Practice Design

NCT03467425

Conditions
Chronic Disease, Disease Attributes, Lung Diseases, +5 more
Locations
  • GSK Investigational Site Aschaffenburg, Bavaria, Germany
  • GSK Investigational Site Dachau, Bavaria, Germany
  • GSK Investigational Site Garmisch-Partenirchen, Bavaria, Germany
  • GSK Investigational Site Wallerfing, Bavaria, Germany
View all 143 locations
View Trial Details
Completed

Safety and Tolerability of Repeat Dosing of GSK233705/GW642444 in COPD

NCT00749411

Conditions
Bronchial Diseases, Bronchitis, Bronchitis, Chronic, +11 more
Locations
  • GSK Investigational Site Mobile, Alabama, United States
  • GSK Investigational Site Wheat Ridge, Colorado, United States
  • GSK Investigational Site Biddeford, Maine, United States
  • GSK Investigational Site St Louis, Missouri, United States
View Trial Details
Completed

Batefenterol/Fluticasone Furoate in Treatment of Chronic Obstructive Pulmonary Disease

NCT02573870

Conditions
Chronic Disease, Disease Attributes, Lung Diseases, +5 more
Locations
  • GSK Investigational Site Phoenix, Arizona, United States
  • GSK Investigational Site Hollywood, Florida, United States
  • GSK Investigational Site Baltimore, Maryland, United States
  • GSK Investigational Site Charlotte, North Carolina, United States
View Trial Details
Completed

Comparative Study of ELLIPTA Dry Powder Inhaler (DPI) Versus DISKUS DPI Used With HandiHaler DPI in Subjects With Chronic Obstructive Pulmonary Disease (COPD)

NCT03227445

Conditions
Chronic Disease, Disease Attributes, Lung Diseases, +5 more
Locations
  • GSK Investigational Site Orlando, Florida, United States
  • GSK Investigational Site Natchitoches, Louisiana, United States
  • GSK Investigational Site Saint Charles, Missouri, United States
  • GSK Investigational Site Charlotte, North Carolina, United States
View all 18 locations
View Trial Details
Completed

A 24 Week Efficacy Study of Inhaled Umeclidinium (UMEC) in Patients of Chronic Obstructive Pulmonary Disease (COPD) Using a Novel Dry Powder Inhaler (NDPI)

NCT02184611

Conditions
Chronic Disease, Disease Attributes, Lung Diseases, +5 more
Locations
  • GSK Investigational Site Guangzhou, Guangdong, China
  • GSK Investigational Site Zhanjiang, Guangdong, China
  • GSK Investigational Site Haikou, Hainan, China
  • GSK Investigational Site Hohhot, Inner Mongolia, China
View all 26 locations
View Trial Details

Related conditions